This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oster, P.
Right arrow Articles by Rossolini, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oster, P.
Right arrow Articles by Rossolini, G. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 1999, p. 2510-2512, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates

Philipp Oster,1 Alessandra Zanchi,1 Stefania Cresti,1,2 Maria Lattanzi,1 Francesca Montagnani,1 Carla Cellesi,1 and Gian Maria Rossolini2,*

Istituto di Clinica delle Malattie Infettive1 and Dipartimento di Biologia Molecolare, Sezione di Microbiologia,2 Università di Siena, 53100-Siena, Italy

Received 16 February 1999/Returned for modification 19 May 1999/Accepted 27 July 1999

Erythromycin resistance rates were found to be increased, from 7.1 in 1993 to 32.8% in 1997, among community-acquired Streptococcus pneumoniae isolates from the Siena area of central Italy. Most of the erythromycin-resistant isolates carried ermAM determinants and were also resistant to josamycin and clindamycin, whereas a minority (5.8%) carried mefA determinants and remained susceptible to the latter drugs.


* Corresponding author. Mailing address: Dipartimento di Biologia Molecolare, Sezione di Microbiologia, Università di Siena, Via Laterina, 8, 53100 Siena, Italy. Phone: 39 0577 233455. Fax: 39 0577 233325. E-mail: rossolini{at}unisi.it.


Antimicrobial Agents and Chemotherapy, October 1999, p. 2510-2512, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rantala, M., Huikko, S., Huovinen, P., Jalava, J., the Finnish Study Group for Antimicrobial Resistan, (2005). Prevalence and Molecular Genetics of Macrolide Resistance among Streptococcus pneumoniae Isolates Collected in Finland in 2002. Antimicrob. Agents Chemother. 49: 4180-4184 [Abstract] [Full Text]  
  • Erdem, G., Ford, J., Johnson, D., Abe, L., Yamaga, K., Kaplan, E. (2005). Erythromycin-Resistant Group A Streptococcal Isolates Collected between 2000 and 2005 in Oahu, Hawaii, and Their emm Types. J. Clin. Microbiol. 43: 2497-2499 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Mouton, J. W. (2005). Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278 [Full Text]  
  • Kasahara, K., Maeda, K., Mikasa, K., Uno, K., Takahashi, K., Konishi, M., Yoshimoto, E., Murakawa, K., Kita, E., Kimura, H. (2005). Clonal Dissemination of Macrolide-Resistant and Penicillin-Susceptible Serotype 3 and Penicillin-Resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae Isolates in Japan: a Pilot Surveillance Study. J. Clin. Microbiol. 43: 1640-1645 [Abstract] [Full Text]  
  • Wierzbowski, A. K., Swedlo, D., Boyd, D., Mulvey, M., Nichol, K. A., Hoban, D. J., Zhanel, G. G. (2005). Molecular Epidemiology and Prevalence of Macrolide Efflux Genes mef(A) and mef(E) in Streptococcus pneumoniae Obtained in Canada from 1997 to 2002. Antimicrob. Agents Chemother. 49: 1257-1261 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Ednie, L. M., Bozdogan, B., Katopodis, G. D., Beratis, N. G., Davies, T. A., Appelbaum, P. C. (2003). Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A). Antimicrob. Agents Chemother. 47: 2699-2702 [Abstract] [Full Text]  
  • Danesi, R., Lupetti, A., Barbara, C., Ghelardi, E., Chella, A., Malizia, T., Senesi, S., Angeletti, C. A., Del Tacca, M., Campa, M. (2003). Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother 51: 939-945 [Abstract] [Full Text]  
  • Gaynor, B D, Holbrook, K A, Whitcher, J P, Holm, S O, Jha, H C, Chaudhary, J S P, Bhatta, R C, Lietman, T (2003). Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year. Br J Ophthalmol 87: 147-148 [Abstract] [Full Text]  
  • Amezaga, M. R., Carter, P. E., Cash, P., McKenzie, H. (2002). Molecular Epidemiology of Erythromycin Resistance in Streptococcus pneumoniae Isolates from Blood and Noninvasive Sites. J. Clin. Microbiol. 40: 3313-3318 [Abstract] [Full Text]  
  • Cresti, S., Lattanzi, M., Zanchi, A., Montagnani, F., Pollini, S., Cellesi, C., Rossolini, G. M. (2002). Resistance Determinants and Clonal Diversity in Group A Streptococci Collected during a Period of Increasing Macrolide Resistance. Antimicrob. Agents Chemother. 46: 1816-1822 [Abstract] [Full Text]  
  • Del Grosso, M., Iannelli, F., Messina, C., Santagati, M., Petrosillo, N., Stefani, S., Pozzi, G., Pantosti, A. (2002). Macrolide Efflux Genes mef(A) and mef(E) Are Carried by Different Genetic Elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40: 774-778 [Abstract] [Full Text]  
  • Moodley, P., Pillay, C., Goga, R., Kharsany, A. B. M., Sturm, A. W. (2001). Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management. J Antimicrob Chemother 48: 853-859 [Abstract] [Full Text]  
  • Mitten, M. J., Meulbroek, J., Nukkala, M., Paige, L., Jarvis, K., Oleksijew, A., Tovcimak, A., Hernandez, L., Alder, J. D., Ewing, P., Or, Y. S., Ma, Z., Nilius, A. M., Mollison, K., Flamm, R. K. (2001). Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections. Antimicrob. Agents Chemother. 45: 2585-2593 [Abstract] [Full Text]  
  • Bonnefoy, A., Guitton, M., Delachaume, C., Le Priol, P., Girard, A.-M. (2001). In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models. Antimicrob. Agents Chemother. 45: 1688-1692 [Abstract] [Full Text]  
  • Martin, S. J., Garvin, C. G., McBurney, C. R., Sahloff, E. G. (2001). The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 47: 581-587 [Abstract] [Full Text]  
  • Ip, M., Lyon, D. J., Yung, R. W. H., Chan, C., Cheng, A. F. B. (2001). Macrolide Resistance in Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 45: 1578-1580 [Abstract] [Full Text]  
  • Montanari, M. P., Mingoia, M., Giovanetti, E., Varaldo, P. E. (2001). Differentiation of Resistance Phenotypes among Erythromycin-Resistant Pneumococci. J. Clin. Microbiol. 39: 1311-1315 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  
  • Jetté, L. P., Delage, G., Ringuette, L., Allard, R., De Wals, P., Lamothe, F., Loo, V., the Pneumococcus Study Group, (2001). Surveillance of Invasive Streptococcus pneumoniae Infection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial Susceptibility, and Clinical Characteristics. J. Clin. Microbiol. 39: 733-737 [Abstract] [Full Text]  
  • Depardieu, F., Courvalin, P. (2001). Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45: 319-323 [Abstract] [Full Text]  
  • Okamoto, H., Miyazaki, S., Tateda, K., Ishii, Y., Yamaguchi, K. (2000). Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan. J Antimicrob Chemother 46: 797-802 [Abstract] [Full Text]  
  • Santagati, M., Iannelli, F., Oggioni, M. R., Stefani, S., Pozzi, G. (2000). Characterization of a Genetic Element Carrying the Macrolide Efflux Gene mef(A) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 2585-2587 [Abstract] [Full Text]  
  • Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J. (2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother. 44: 1838-1841 [Abstract] [Full Text]